Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana) vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic.
Chaudhary
A
A
Department of G. I. Surgery, GB Pant Hospital, New Delhi.
Gupta
R L
RL
D000293:Adolescent; D000328:Adult; D001577:Benzophenones / Q000009:adverse effects / Q000627:therapeutic use*; D001660:Biliary Tract Diseases / Q000188:drug therapy* / Q000209:etiology; D003085:Colic / Q000188:drug therapy* / Q000209:etiology; D004008:Diclofenac / Q000009:adverse effects / Q000627:therapeutic use*; D004177:Dipyrone / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D014515:Ureteral Diseases / Q000188:drug therapy* / Q000209:etiology
D001577:Benzophenones; D004338:Drug Combinations; D010276:Parasympatholytics; D010880:Piperidines; C118979:manyana; D004008:Diclofenac; D004177:Dipyrone; C002416:fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination